Processa Pharmaceuticals, Inc. — Director's Dealing 2020

Oct 2, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Processa Pharmaceuticals, Inc. (PCSA)
CIK: 0001533743
Period of Report: 2020-10-02

Reporting Person: Bigora Sian (Chief Development Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	389725	Direct
Common Stock	132702	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$16.80	2024-06-20	Common Stock (7859)		Direct
Stock Options (Right to buy)	$16.80	2024-06-20	Common Stock (8664)		Direct

Footnotes

F1: Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.

F2: Stock options vest upon meeting certain performance criteria.